CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization

Go back to CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
(NASDAQ: CRVO) Delayed: 3.02 +0.09 (3.07%)
Previous Close $2.93    52 Week High $ 
Open $2.96    52 Week Low $ 
Day High $3.07    P/E N/A 
Day Low $2.88    EPS $ 
Volume 225,514